Brief: Immunoprecise Antibodies Announces Transfer To Nasdaq Capital Market And Extension Of Bid Price Compliance Period
20/02/2025 13:01
Feb 20 (Reuters) - Immunoprecise Antibodies Ltd IPA.O :
* IMMUNOPRECISE ANTIBODIES ANNOUNCES TRANSFER TO NASDAQ
CAPITAL
MARKET AND EXTENSION OF BID PRICE COMPLIANCE PERIOD
Source text: ID:nBw6mGczVa
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai